Eric Feigl-Ding
(Redirected from Eric Feigl Ding)
Eric Feigl-Ding is an American epidemiologist and health economist. He is a Senior Fellow at the Federation of American Scientists in Washington D.C., where he leads the organization's efforts on the COVID-19 pandemic and its Project on Government Secrecy.
Early life and education[edit | edit source]
Feigl-Ding was born in Shanghai, China, and immigrated to the United States at a young age. He received his Bachelor's degree in Nutrition from the Johns Hopkins University and his Doctor of Science (Sc.D.) degree in Epidemiology and Nutrition from the Harvard T.H. Chan School of Public Health.
Career[edit | edit source]
Feigl-Ding began his career as a faculty member at the Harvard T.H. Chan School of Public Health. He has conducted extensive research on cardiovascular disease, diabetes, and cancer epidemiology, as well as health policy and health economics.
In 2020, Feigl-Ding gained prominence for his early warnings about the severity of the COVID-19 pandemic. He has since been a vocal advocate for public health measures to combat the virus, including social distancing, mask wearing, and vaccination.
Research[edit | edit source]
Feigl-Ding's research focuses on the intersection of epidemiology, nutrition, and health economics. He has published numerous peer-reviewed articles in these fields. His work has been cited in various media outlets, including The New York Times, The Washington Post, and CNN.
Controversies[edit | edit source]
Feigl-Ding has been criticized for his use of social media to disseminate information about the COVID-19 pandemic. Critics argue that his posts can be alarmist and lack context, while supporters argue that he provides valuable information to the public.
References[edit | edit source]
External links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD